ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy
Floris H. Groenendijk(The Netherlands Cancer Institute), Jeroen de Jong(Oncode Institute), Elisabeth E. Fransen van de Putte(The Netherlands Cancer Institute), Magali Michaut(The Netherlands Cancer Institute), Andreas Schlicker(Cancer Genomics Centre), Dennis Peters(The Netherlands Cancer Institute), Arno Velds(The Netherlands Cancer Institute), Marja Nieuwland(The Netherlands Cancer Institute), Michel M. van den Heuvel(The Netherlands Cancer Institute), Ron Kerkhoven(The Netherlands Cancer Institute), Lodewijk F.A. Wessels(The Netherlands Cancer Institute), Annegien Broeks(Oncode Institute), Bas W.G. van Rhijn(The Netherlands Cancer Institute), René Bernards(Cancer Genomics Centre), Michiel S. van der Heijden(Cancer Genomics Centre)
Cited by 218
Abstract
Related Papers
No related papers found
Powered by citation graph analysis